Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Omnicell
OMCL
$1.7B
| $29.2M | 0.02% |
256,333
+23,541
| +10% | +$2.7M |
|
|
BPMC
252
DELISTED
Blueprint Medicines
BPMC
| $28.8M | 0.02% |
570,511
+172,456
| +43% | +$10.1M |
|
253
CONMED
CNMD
$1.49B
| $28.4M | 0.02% |
297,074
-7,451
| -2% | -$894K |
|
254
Alcon
ALC
$34.3B
| $27.7M | 0.02% |
395,837
-19,683
| -5% | -$1.44M |
|
|
PXD
255
DELISTED
Pioneer Natural Resource Co.
PXD
| $27.1M | 0.02% |
121,704
+1,617
| +1% | +$410K |
|
256
Biogen
BIIB
$30.7B
| $27.1M | 0.02% |
132,848
+504
| +0.4% | +$103K |
|
257
DexCom
DXCM
$31.2B
| $26.7M | 0.02% |
358,848
-16,768
| -4% | -$1.53M |
|
258
Kulicke & Soffa
KLIC
$4.99B
| $26.5M | 0.02% |
618,783
| – | – |
|
259
Prosperity Bancshares
PB
$8.94B
| $26.3M | 0.02% |
385,267
+71,942
| +23% | +$4.94M |
|
260
Lowe's Companies
LOW
$123B
| $26M | 0.02% |
148,570
+11,370
| +8% | +$2.19M |
|
261
KraneShares CSI China Internet ETF
KWEB
$5.65B
| $25.7M | 0.02% |
783,434
+201,977
| +35% | +$5.8M |
|
262
AAR Corp
AIR
$5.9B
| $24.7M | 0.02% |
589,702
-1,392
| -0.2% | -$65K |
|
|
ARNC
263
DELISTED
Arconic Corporation
ARNC
| $23.6M | 0.02% |
842,714
-14,337
| -2% | -$388K |
|
264
WillScot Mobile Mini Holdings
WSC
$4.84B
| $23.5M | 0.02% |
724,921
-7,875
| -1% | -$279K |
|
|
X
265
DELISTED
US Steel
X
| $23.5M | 0.02% |
1,311,111
-42,522
| -3% | -$1.16M |
|
266
RLJ Lodging Trust
RLJ
$1.89B
| $23.5M | 0.02% |
2,128,855
+97,935
| +5% | +$1.28M |
|
267
Diamondback Energy
FANG
$52.8B
| $23M | 0.02% |
189,562
+1,355
| +0.7% | +$186K |
|
|
SWAV
268
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $22.8M | 0.02% |
119,200
-3,060
| -3% | -$540K |
|
269
Canadian Pacific Kansas City
CP
$80.8B
| $22.5M | 0.02% |
322,129
+118
| +0% | +$8.54K |
|
|
AAWW
270
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $22.2M | 0.02% |
359,938
-16,849
| -4% | -$1.15M |
|
271
Wipro
WIT
$19.8B
| $22M | 0.02% |
8,295,962
+689,626
| +9% | +$2.17M |
|
272
Paylocity
PCTY
$7.79B
| $22M | 0.02% |
126,240
+9,794
| +8% | +$1.78M |
|
273
UnitedHealth
UNH
$377B
| $21.6M | 0.02% |
42,036
-5,302
| -11% | -$2.66M |
|
274
NOV
NOV
$7.02B
| $20.8M | 0.01% |
1,232,815
+2,433
| +0.2% | +$45.8K |
|
275
Sony
SONY
$132B
| $19.6M | 0.01% |
1,200,190
+20,305
| +2% | +$360K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.